title: [Lipids and the size of lipoprotein particles in newly diagnosed and untreated patients with type 2 diabetes mellitus].
abstract: Type 2 diabetes mellitus leads to the typical known form of dyslipidaemia among the patients. This dyslipiademia type re-presents prognostically important type of atherogenic dyslipiadaemia, that significantly increases the risk of atherothrombosis. Estimation of the size of lipoprotein particles with Lipoprint method among newly diagnosed, untreated patients with these patients have not been evaluated yet. Dyslipidaemia among patients with type 2 diabetes mellitus has its course and changes after the treatment. At the beginning i tis characterized by the significant increase of VLDL, large and middle size IDL lipoprotein particles, as well as by lowering of HDL particles. This lipoprotein profile has its own atherogenic potential. The course of the disease later leads to the change of dyslipidaemia, characterized by the increase of LDL levels (small dense particles), triglyceride levels and the persistence of the lower levels of HDLcholesterol. Hypolipidemic treatment leads to the significant lowering of cardiovascular risk, however despite treatment with statin or fibrate residual cardiovascular risk remains still very high.
authors.affiliation: Interná klinika Lekárskej fakulty UK a UN Bratislava, Slovenská republika. andrej.dukat@sm.unb.sk
authors.forename: A
authors.initials: A
authors.lastname: Dukát
authors.forename: L
authors.initials: L
authors.lastname: Fábryová
authors.forename: S
authors.initials: S
authors.lastname: Oravec
authors.forename: P
authors.initials: P
authors.lastname: Sabaka
authors.forename: L
authors.initials: L
authors.lastname: Mistríková
authors.forename: D
authors.initials: D
authors.lastname: Baláž
authors.forename: P
authors.initials: P
authors.lastname: Gavornik
authors.forename: L
authors.initials: L
authors.lastname: Gašpar
mesh_terms: D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications*; D050171:Dyslipidemias / Q000097:blood* / Q000209:etiology; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D012307:Risk Factors
chemical_list: D008055:Lipids; D008074:Lipoproteins